Vale SA
VALE
Petroleo Brasileiro SA Petrobras
PBR
Taylor Morrison Home
TMHC
4
Lennar Corp
LEN
5
KB Home
KBH
US Stock MarketDetailed Quotes
FULC Fulcrum Therapeutics
- 2.995
- -0.095-3.07%
Trading Mar 28 13:42 ET
161.67MMarket Cap-18.72P/E (TTM)
3.130High2.995Low51.84KVolume3.080Open3.090Pre Close157.93KTurnover0.20%Turnover RatioLossP/E (Static)53.98MShares10.13052wk High0.67P/B79.38MFloat Cap2.78052wk Low--Dividend TTM26.50MShs Float33.098Historical High--Div YieldTTM4.37%Amplitude2.250Historical Low3.046Avg Price1Lot Size
Fulcrum Therapeutics Key Stats
EPS
According to the latest financial report of Fulcrum Therapeutics, the latest earnings per share (TTM) for the company is -0.31. Investing in companies with strong earnings per share can potentially provide higher returns.
Currency: USD
Quarterly
Loading...
FCF
Interested in knowing about Fulcrum Therapeutics's free cash flow? The latest report shows it as -16.99M. Keep an eye on and closely monitor the company's cash flow to make informed investment decisions.
Currency: USD
Quarterly
Loading...
Current Ratio
If you are evaluating a company's liquidity, current ratio is an important measure to consider. The latest financial report of Fulcrum Therapeutics shows that the company's current ratio is 22.63, indicating healthy liquidity.
Currency: USD
Quarterly
Loading...
Quick Ratio
Another liquidity indicator to closely monitor is quick ratio. According to the latest financial results of Fulcrum Therapeutics, the quick ratio is 22.13, indicating that the company can meet its short-term debt obligations.
Currency: USD
Quarterly
Loading...
ROE
Want to learn more about the financial health of Fulcrum Therapeutics? The latest ROE figure is -6.62%, indicating that the company has stable profitability.
Currency: USD
Quarterly
Loading...
ROA
Investors looking for profitability indicators may be interested in ROA. According to the latest financial results of Fulcrum Therapeutics, the total asset return on investment (ROA) is -6.14%.
Currency: USD
Quarterly
Loading...
Gross Margin
Gross margin can provide insight into a company's pricing strategy and cost structure. Check Fulcrum Therapeutics's latest financial report to see how their gross margin is doing - currently at --.
Currency: USD
Quarterly
Loading...
Net Margin
For investors focusing on operational efficiency, net profit margin is an important indicator. According to the latest financial results of Fulcrum Therapeutics, the net profit margin is 69.26%, which is a good sign for its profitability.
Currency: USD
Quarterly
Loading...
Market Insights
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
Discussing
Chinese stock earnings surge: Will profit sustain the rally?
1. Which sectors are likely to be market highlights this season? 2. With the government's emphasis on technological innovation and sustaina
Moomoo News Global
Mar 4 23:26
China's Two Sessions: Key Takeaways on Stock Price Movements Before and After the Meetings